Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 2
2022 7
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Ivosidenib and Azacitidine in IDH1-Mutated AML.
Gil-Sierra MD, Briceño-Casado MP, Sierra-Sanchez JF. Gil-Sierra MD, et al. Among authors: briceno casado mp. N Engl J Med. 2022 Jun 30;386(26):2535-2536. doi: 10.1056/NEJMc2206489. N Engl J Med. 2022. PMID: 35767448 Free article. No abstract available.
Patient benefit as a goal of humanization.
Gil-Sierra MD, Briceño-Casado MDP, López-Briz E. Gil-Sierra MD, et al. Among authors: briceno casado mdp. Farm Hosp. 2022 Oct 4;46(6):367-371. Farm Hosp. 2022. PMID: 36520577 English.
Biomarker Analysis of Vistusertib Plus Paclitaxel Regimen.
Gil-Sierra MD, Briceño-Casado MDP, Moreno-Ramos C. Gil-Sierra MD, et al. Among authors: briceno casado mdp. JAMA Oncol. 2023 Nov 1;9(11):1585-1586. doi: 10.1001/jamaoncol.2023.3398. JAMA Oncol. 2023. PMID: 37676676 No abstract available.
Inclusion of omalizumab in a trastuzumab desensitization protocol.
Barreiro-Fernández EM, Gil-Sierra MD, Briceño-Casado MDP, Martínez-Díaz C, Ríos-Sánchez E. Barreiro-Fernández EM, et al. Among authors: briceno casado mdp. Farm Hosp. 2022 Mar 26;46(3):199-201. Farm Hosp. 2022. PMID: 36183214 English. No abstract available.
Belantamab mafodotin for relapsed or refractory multiple myeloma.
Gil-Sierra MD, Briceño-Casado MDP. Gil-Sierra MD, et al. Among authors: briceno casado mdp. J Oncol Pharm Pract. 2022 Sep;28(6):1375-1380. doi: 10.1177/10781552221086265. Epub 2022 Mar 21. J Oncol Pharm Pract. 2022. PMID: 35306910
Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses.
Gil-Sierra MD, Briceño-Casado MDP, Fénix-Caballero S, Alegre-Del Rey EJ, de la Lastra-Romero CA, Sánchez-Hidalgo M. Gil-Sierra MD, et al. Among authors: briceno casado mdp. J Oncol Pharm Pract. 2023 Jan;29(1):155-161. doi: 10.1177/10781552211062144. Epub 2021 Nov 30. J Oncol Pharm Pract. 2023. PMID: 34846221
13 results